eNewsroom for: NI Research

http://pressreleaseheadlines.com/wp-content/Cimy_User_Extra_Fields/NI Research/niresearch.png

NI Research Company Profile

NI Research is the leading publisher of independent research on the neuropharmaceutical/therapeutic industry. NI Research has published NeuroPerspective (formerly NeuroInvestment) since 1995; the Private CNS Company Review since 2003; and CNS Therapeutics and Licensing since 2007. NI Research has developed an unmatched information base regarding both publicly and privately held neurotherapeutics companies, and offers M&A/licensing consultation services.

News from NI Research:

Depression Reviewed by NeuroPerspective

CARDIFF, Calif., May 6, 2014 /PRNewswire/ – NI Research has released the May issue of NeuroPerspective, which features a comprehensive review of pharmacotherapies for depression, with a particular focus upon the companies developing RAADs, rapid-acting antidepressants, an appro…

Migraine Reviewed by NeuroPerspective

CARDIFF, Calif., April 8, 2014 /PRNewswire/ — NI Research has released the April issue of NeuroPerspective, which reviews and assesses migraine therapeutics in development.
Migraine is the most common of all neurological disorders. Based on epidemiological studies done in the US and Europe d…

Huntington's Reviewed by NeuroPerspective

CARDIFF, Calif., March 4, 2014 /PRNewswire/ — NI Research has released the March issue of NeuroPerspective, which reviews and assesses the range of neurotherapeutics programs in development for Huntington's Disease. Huntington's is a devastating orphan neurodegenerative diso…

Alzheimer's Therapeutics Reviewed by NeuroPerspective

CARDIFF, Calif., Sept. 12, 2013 /PRNewswire/ — NI Research (NIR) has released the September issue of NeuroPerspective, which features a comprehensive review of Alzheimer's therapeutics at http://www.niresearch.com/onlinestore.html.
Alzheimer's  constitutes the s…

Parkinson's Therapeutics Reviewed by NeuroPerspective

CARDIFF, Calif., May 6, 2013 /PRNewswire/ — NI Research, the leading publisher of independent research on the neurotherapeutics industry, has released the May issue of NeuroPerspective, which reviews the status and prospects of therapeutics for Parkinson's.
"The current therap…

Schizophrenia and Its Treatment Reviewed by NeuroPerspective

CARDIFF, Calif., March 19, 2013 /PRNewswire/ – NI Research has released the March issue of NeuroPerspective. The issue features a comprehensive review of schizophrenia, with a focus on the progress being made in developing therapies that go beyond the blunting of the hallucinations and delu…

ALS Reviewed by NeuroPerspective

CARDIFF, Calif., Feb. 11, 2013 /PRNewswire/ – NI Research has released the February issue of NeuroPerspective. The issue features a comprehensive review of ALS, and the continuing but frustrating search for a genuinely useful treatment for the treatment of this devastating illness.
"…

Rapid-Acting Antidepressants Reviewed by NeuroPerspective

CARDIFF, Calif., Dec. 11, 2012 /PRNewswire/ – NI Research has released the December issue of NeuroPerspective, which features a comprehensive review of pharmacotherapies for depression, with a particular focus upon the programs developing RAADs, rapid-acting antidepressants, an appro…

Alzheimer's Therapeutics Reviewed by NeuroPerspective

CARDIFF, Calif., Sept. 6, 2012 /PRNewswire/ — NI Research has released the September issue of NeuroPerspective, which features a comprehensive review of Alzheimer's therapeutics. The focus is particularly timely, given the recent release of Phase III results for bapineuzumab and sola…

Stroke Reviewed by NeuroPerspective

CARDIFF, Calif., May 16, 2012 — NeuroPerspective, the independent, monthly review of the neurotherapeutics area, has released its May issue, which assesses the field of therapeutics for stroke.
"We have been waiting for good news in stroke for a long time, and it remains elusive for pharma…

Private CNS Company Review 2012 Released by NI Research

CARDIFF, Calif., March 8, 2012 — NI Research, the publisher of independent and authoritative reviews of the neurotherapeutics area, has released the 2012 edition of the Private CNS Company Review. PCNS provides a unique database of information about the private companies specializing in the d…